Sernova Corp (SVA) - Financial and Strategic SWOT Analysis Review

Sernova Corp (SVA) - Financial and Strategic SWOT Analysis Review

  • Products Id :- GDME2315FSA
  • |
  • Pages: 35
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Sernova Corp (SVA)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Sernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases. The company develops Cell Pouch System, an implantable medical device, which offers a natural organ-like environment for the long term survival and function of insulin producing islets for the treatment of diabetes. Sernova uses proprietary local immune protection technologies that protect therapeutic cells within the Cell Pouch from immune system. The company's product portfolio addresses metabolic diseases such as insulin dependent diabetes and thyroid disease; and blood disorders such as hemophilia A; and other neurological ailments. Sernova is headquartered in London, Ontario, Canada.

Sernova Corp Key Recent Developments

Jul 23,2018: Sernova Completes Oversubscribed Private Placement of USD 2,754,000

Jun 26,2018: Sernova Announces USD 2 Million Private Placement Financing

May 04,2018: Sernova Announces Results of 2018 Annual General Meeting of Shareholders and New Chief Financial Officer

Feb 14,2018: The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor Day

Jun 05,2017: Sernova Provides Company Outlook on Corporate and Clinical Developments

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Sernova Corp-Key Facts 5

Sernova Corp-Key Employees 6

Sernova Corp-Key Employee Biographies 7

Sernova Corp-Major Products and Services 8

Sernova Corp-History 9

Sernova Corp-Locations And Subsidiaries 11

Head Office 11

Section 2-Company Analysis 12

Company Overview 12

Sernova Corp-Business Description 13

Sernova Corp-Corporate Strategy 14

Sernova Corp-SWOT Analysis 15

SWOT Analysis-Overview 15

Sernova Corp-Strengths 15

Sernova Corp-Weaknesses 16

Sernova Corp-Opportunities 17

Sernova Corp-Threats 18

Sernova Corp-Key Competitors 19

Section 3-Company Financial Ratios 20

Financial Ratios-Capital Market Ratios 20

Financial Ratios-Annual Ratios 21

Performance Chart 22

Financial Performance 22

Financial Ratios-Interim Ratios 23

Financial Ratios-Ratio Charts 24

Section 4-Company's Lifesciences Financial Deals and Alliances 25

Sernova Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 25

Sernova Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018 26

Sernova Corp, Recent Deals Summary 27

Section 5-Company's Recent Developments 28

May 04, 2018: Sernova Announces Results of 2018 Annual General Meeting of Shareholders and New Chief Financial Officer 28

Jun 05, 2017: Sernova Provides Company Outlook on Corporate and Clinical Developments 30

Section 6-Appendix 31

Methodology 31

Ratio Definitions 31

About GlobalData 35

Contact Us 35

Disclaimer 35

List of Figures

Sernova Corp, Performance Chart (2013-2017) 22

Sernova Corp, Ratio Charts 24

Sernova Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 25

Sernova Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 26

List of Tables

Sernova Corp, Key Facts 5

Sernova Corp, Key Employees 6

Sernova Corp, Key Employee Biographies 7

Sernova Corp, Major Products and Services 8

Sernova Corp, History 9

Sernova Corp, Key Competitors 19

Sernova Corp, Ratios based on current share price 20

Sernova Corp, Annual Ratios 21

Sernova Corp, Interim Ratios 23

Sernova Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 25

Sernova Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018 26

Sernova Corp, Recent Deals Summary 27

Currency Codes 31

Capital Market Ratios 31

Equity Ratios 32

Profitability Ratios 32

Cost Ratios 33

Liquidity Ratios 33

Leverage Ratios 34

Efficiency Ratios 34

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

MedImmune LLC

Generex Biotechnology Corp

Diamyd Medical AB

ConjuChem LLC

Alnara Pharmaceuticals Inc

Sernova Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8750
Site License
USD 250 INR 17500
Corporate User License
USD 375 INR 26250



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]